Search

Maria Patzwald, a 38-year-old woman, shares her experience of being part of a pioneering clinical trial aimed at treating preeclampsia, a potentially fatal pregnancy complication, which helped extend her pregnancy by ten days, leading to the safe birth of her son at 34 weeks, significantly improving his chances of survival. #PregnancyHealth #PreEclampsia #MaternalCare #US #DE #GB

Maria Patzwald, a 38-year-old pregnant woman diagnosed with severe preeclampsia, participated in a pioneering trial aimed at treating the condition, which affects maternal and neonatal health, and was able to have her son born at 34 weeks, significantly improving his chances of survival. #PregnancyHealth #PreEclampsia #MaternalHealth #US #DE #GB

A pioneering study published in Nature Medicine suggests that a blood filtration technique, known as apheresis, can safely reduce levels of the placental protein sFlt-1 and lower blood pressure in early-onset severe preeclampsia, potentially delaying disease progression and improving outcomes for both mother and baby, although larger controlled trials are needed to confirm these findings. #Preeclampsia #PregnancyHealth #MedicalResearch #Nocountrycodesarementionedinthearticle.

A study from the University of Nebraska, published in Molecular Psychiatry, found that children whose mothers took certain medications during pregnancy, particularly those affecting cholesterol production, had a 47% increased risk of autism diagnosis, with the risk amplifying for those whose mothers used four or more such drugs simultaneously; however, the researchers emphasized that this is an associative study and does not confirm causation, suggesting that underlying maternal mental health may also play a role. #AutismResearch #PregnancyHealth #MedicationImpact